Similar articles

• A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

  Holcomb K, Weinberg JM. Holcomb K, et al. J Drugs Dermatol. 2006 Oct;5(9):863-6. J Drugs Dermatol. 2006. PMID: 17039651 Review.
• Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

  Betts RF. Betts RF. J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7. doi: 10.1016/j.jaad.2007.09.017. J Am Acad Dermatol. 2007. PMID: 18021866 Clinical Trial.
• Vaccination: a new option to reduce the burden of herpes zoster.

  Mick G. Mick G. Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32. Expert Rev Vaccines. 2010. PMID: 20192716 Review.
• [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006;Spec no.1:14-5. MMW Fortschr Med. 2006. PMID: 16872127 German. No abstract available.
• [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].

  Marino MG, Bagnato B, Torella I, Franco E. Marino MG, et al. Ig Sanita Pubbl. 2009 May-Jun;65(3):299-311. Ig Sanita Pubbl. 2009. PMID: 19629155 Italian.